Artificial intelligence and polyclonal antibody sequencing redefine the future of antibody discovery
insights from industryDr. Xiabing HanPrincipal Scientist for Antibody DiscoveryRapid Novor In this interview, News-Medical had the opportunity to speak with Dr. Xiaobing Han, Principal Scientist for ...
A new study shows that long-read sequencing has the potential to improve the rate of diagnosis while reducing the time to diagnosis from years to days -- in a single test and at a much lower cost. One ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results